Related Experiment Videos
[Medallion lenses, 500 implantations]
Klinische Monatsblatter Fur Augenheilkunde
|February 1, 1983
Summary
The Medallion intraocular lens showed excellent performance in 500 cataract surgeries, with few severe complications. Late complications were rare in uneventful cases, suggesting good long-term safety for this implant.
Area of Science:
- Ophthalmology
- Biomaterials Science
- Surgical Innovation
Context:
- Intracapsular cataract extraction (ICCE) remains a significant surgical approach globally.
- Intraocular lens (IOL) technology has evolved, with a shift towards posterior chamber lenses.
- Long-term safety and efficacy data for older IOL designs are crucial for clinical decision-making.
Purpose:
- To evaluate the long-term safety and efficacy of the Medallion intraocular lens (IOL).
- To assess complication rates associated with Medallion IOL implantation following intracapsular cataract surgery.
- To compare the performance of the Medallion IOL with modern intraocular lens designs.
Summary:
- A cohort of 500 Medallion IOLs were implanted, predominantly after ICCE (88%).
- Follow-up ranged from 3 to 88 months (average 22 months), revealing severe keratopathy in 1.2% of cases due to surgical trauma, decentration, or wound rupture.
- Excellent lens performance was observed overall, with no late complications involving the iris or cornea in uneventful cases, indicating low risk for such scenarios.
Impact:
- Provides valuable long-term data on the Medallion IOL, supporting its continued use in specific clinical situations.
- Highlights the importance of surgical technique and uneventful postoperative recovery for minimizing complications.
- Informs the ongoing discussion about IOL selection, acknowledging potential advantages of newer posterior chamber lens designs.